More importantly, in a panel of HCC cell lines with varying degrees of COPS5 expression, there was a negative correlation between COPS5 expression and sorafenib sensitivity (Figure 1N), suggesting its potential role in driving sorafenib resistance in HCC. The gene discussed is COPS5; the disease is hepatocellular carcinoma.